Manufacturing News of Note: Catalent expands; Hospira and Novartis issue recalls


> Catalent is investing $9 million in a clinical supply facility in San Diego, California. Release

> Nichi-Iko Pharmaceutical, parent of Sagent Pharmaceuticals, says its Canadian subsidiary, Omega Laboratories, has won FDA approval for its site in Montreal to manufacture products for the U.S. Release

> Pfizer's Hospira is voluntarily recalling one lot of bacteriostatic water used to dilute drugs because vials may not be sterile and bring a risk of bacterial infections. Release

Watch the Free Webinar

Chemistry Through Biology: Translating Molecular Biology Technologies into Practical Processes for API Production

Learn about the key advances and critical hurdles in transforming emerging molecular biology technologies into practical applications with commercially viable processes.

> Novartis is recalling one lot of asthma med Xolair in Canada because the vials may include silicone oil. Release

Suggested Articles

Vir struck a manufacturing deal with Samsung to boost production of two novel antibodies that could prove effective as a treatment for COVID-19.

Pfizer and BioNTech could have "millions" of doses of a potential COVID-19 vaccine ready to go this year if they start human testing this month.

Mylan will donate millions of doses of hydroxychloroquine "ahead of schedule" after ramping up production for the potential COVID-19 therapy.